⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARVN News
Arvinas, Inc
Arvinas to Participate in Upcoming Investor Conferences
globenewswire.com
ARVN
Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
globenewswire.com
ARVN
Arvinas Announces Appointment of Randy Teel, Ph.D., as President, Chief Executive Officer, and Director
globenewswire.com
ARVN
PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight
prnewswire.com
ARVN
PFE
BioCT Brings Legislators, Academia, and Industry Leaders Together to Strengthen Connecticut’s Life Sciences Sector Ahead of 2026 Session
businesswire.com
ARVN
New nanoparticle technology offers hope for hard-to-treat diseases
globenewswire.com
ARVN
PFE
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
businesswire.com
QTRX
ILMN
EXAS
DGX
PFE
ARVN
Silver Dollar City Honors America's 250th with Free Season Passports for Active Military, season-long celebrations
prnewswire.com
ARVN
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
globenewswire.com
ARVN
Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
ARVN